Effects of sleep quality on the risk of various long COVID symptoms among older adults following infection: an observational study.

Publication date: Jan 09, 2025

The long-term sequelae of coronavirus disease 2019 (COVID-19) and its recovery have becoming significant public health concerns. Therefore, this study aimed to enhance the limited evidence regarding the relationship between sleep quality on long COVID among the older population aged 60 years or old. Our study included 4,781 COVID-19 patients enrolled from April to May 2023, based on the Peking University Health Cohort. Sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI) scale. Long COVID was evaluated by well-trained health professionals through patients’ self-reported symptoms. Binary logistic regression models were employed to calculate odds ratios (OR) and 95% confidence intervals (95% CI). The prevalence of long COVID among older adults was 57. 4% (2,743/4,781). Specifically, the prevalence of general symptoms, cardiovascular symptoms, respiratory symptoms, gastrointestinal symptoms, and neurological and psychiatric symptoms was 47. 7% (2,282/4,781), 3. 4% (163/4,781), 35. 2% (1683/4,781), 8. 7% (416/4,781) and 5. 8% (279/4,781), respectively. For each one-point increase in PSQI scores, the risk of long COVID, general symptoms, cardiovascular symptoms, gastrointestinal symptoms, and neurological and psychiatric symptoms increased by 3% (95% CI: 1. 01, 1. 06), 3% (95% CI: 1. 01, 1. 06), 7% (95% CI: 1. 01, 1. 13), 11% (95% CI: 1. 07, 1. 15), and 20% (95% CI: 1. 15, 1. 25), respectively. In multivariate models, compared with good sleepers, COVID-19 patients with poor sleep quality exhibited an increased risk of general symptoms (aOR = 1. 17; 95% CI: 1. 03, 1. 33), cardiovascular symptoms (aOR = 1. 50; 95% CI: 1. 06, 2. 14), gastrointestinal symptoms (aOR = 2. 03; 95% CI: 1. 61, 2. 54), and neurological and psychiatric symptoms (aOR = 2. 57; 95% CI = 1. 96, 3. 37). Our findings indicate that poor sleep quality is related to various manifestations of long COVID in older populations. A comprehensive assessment and multidisciplinary management of sleep health and long COVID may be essential to ensure healthy aging in the future.

Open Access PDF

Concepts Keywords
Gastrointestinal Aged
Professionals Aged, 80 and over
Sleep China
Chinese
COVID-19
Female
Humans
Long COVID
Male
Middle Aged
Older adults
Post-Acute COVID-19 Syndrome
Prevalence
PSQI
Risk Factors
SARS-CoV-2
Sleep Quality
Sleep quality
Sleep Wake Disorders

Semantics

Type Source Name
disease MESH sleep quality
disease MESH long COVID
disease MESH infection
disease MESH sequelae
disease MESH coronavirus disease 2019
pathway REACTOME Reproduction
drug DRUGBANK Coenzyme M
disease MESH morbidity
disease MESH dyspnea
disease MESH anxiety
disease IDO susceptibility
disease MESH convalescence
disease MESH lifestyle
disease MESH sleep disorders
disease IDO history
disease MESH sleep latency
disease MESH neuralgia
disease MESH hair loss
disease MESH sore throat
disease MESH nasal obstruction
disease MESH dysphagia
disease MESH chest pain
drug DRUGBANK Trestolone
disease MESH depression
disease MESH educational level
disease MESH marital status
disease MESH cognitive impairment
disease MESH Obesity
drug DRUGBANK Sodium lauryl sulfate
disease MESH chronic diseases
drug DRUGBANK Ethanol
disease MESH Overweight
drug DRUGBANK Isoxaflutole
disease IDO symptom
disease MESH causality
drug DRUGBANK Ranitidine
disease IDO intervention
drug DRUGBANK Guanosine
disease MESH neurological disorders
drug DRUGBANK Copper
disease MESH hypertension
disease MESH dementia
disease MESH insomnia
disease MESH Inflammation
disease MESH Sleep Deprivation
disease MESH Asthma
pathway KEGG Asthma
disease MESH communicable Disease

Original Article

(Visited 1 times, 1 visits today)